In evaluating medical evidence, subgroup analysis plays a critical role. Is the patient you are treating like those studied in the trial? And if this is generally true (e.g., a ruptured aneurysm patient), is it specifically true (e.g., an older patient with a ruptured middle cerebral artery [MCA] aneurysm)?